Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum effective concentration and volume of ropivacaine for spinal anesthesia in anorectal day surgery
ChiCTR2300074796Phase 4Not yet recruiting
- Sponsor
- Fengdu County People's Hospital
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in anal fistula, perianal abscess and hemorrhoid, sponsored by Fengdu County People's Hospital. Primary endpoints: Modified Bromage score at end of surgery, 90% minimum effective concentration (MEV90) of ropivacaine for spinal anesthesia and 1 more. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
anal fistulaperianal abscesshemorrhoid
Beyond the preview
Go deeper on ChiCTR2300074796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074796.